that it will use the proceeds from its IPO for research and development, expanding its manufacturing capabilities, and to fund the clinical development of its potential coronavirus vaccine through the completion of its Phase 3 trial.
The company in June started its Phase 1 coronavirus vaccine trial with healthy human participants, and expects results in the fourth quarter of the year, according to theIn addition to the coronavirus, CureVac is working on vaccines for rabies and other infectious diseases as well as treatments for tumors, cancers, and other diseases.
"Our vision is to revolutionize medicine and open new avenues for developing therapies by enabling the body to make its own drugs," the company said in the filing.
Article's not available anymore. Would love to find an archive.
__Adedeji how can we get news of stuff like this before it happens now 🗣🗣
Why has the pharmaceuticals industry moved into a vaccine race? What's the business behind vaccine development that makes pharma giants clash? 👇 Pharma Pharmaceuticals Business BusinessModel Strategy COVID19
Connecting the dots
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »